Accrued Expenses

12 Months Ended

Dec. 31, 2014

Accrued Expenses

Accrued Expenses

5. Accrued Expenses

At December 31, 2014 and 2013, accrued expenses consisted of the following (in thousands):

	December 31,
	2014		2013
Investor deposit	$	—	$	500
Payroll and related costs	419		204
Clinical trials and drug development	777		73
Professional fees	186		295
Other	121		24
	$	1,503	$	1,096

Investor deposit represents funds received from an investor for 422,119 shares of Series C Preferred Stock. The shares were issued in April 2014.